The Trump administration is giving private plans more power to negotiate to lower drug prices for seniors for physician-administered drugs.
The Centers for Medicare & Medicaid Services said that the new policy is part of a greater effort by the Trump administration to lower drug prices. The agency’s new policy applies to Medicare Advantage, a program that lets seniors use their Medicare benefits to buy a private plan.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.